TL44: Modeling the dissimilarities of Test-Reference concentration curves in post-marketing safety/ surveillance studies of generic drugs
*Elena Rantou, FDA/CDER Keywords: "In an attempt to model the differences of the plasma concentration curves of the Test and Reference formulations in a post-marketing safety/ surveillance study of a generic drug, there are numerous issues to be addressed as the presence of outliers and the critical concentration times. Critical times can be characterized as the ones that determine either the maximum separation or the highest similarity between the two curves. The choice of the appropriate statistical approach to detect critical times should depend on the distributional properties of the data, the variance/ covariance structure and the fact that concentration times are not equally spaced. These lead to the modification of some similarity measures in such a way that are sensitive to changes between consecutive times. In addition, we can construct an acceptance region of the difference Test-Reference, at specific time points. If the above techniques can be standardized so that they yield comparable results from different studies, they can be extended to comparing two or more generic drugs. "
|
Key Dates
-
November 1 - December 17, 2013
Online proposal submission for a session, short course and Town Hall Open -
January 6 - March 11, 2014
Online proposal submission for Roundtables Open -
April 30 - May 28, 2014
Abstract Submission Open -
June 4, 2014
Online Registration Opens -
August 8 - August 22, 2014
Invited Abstract Editing -
August 11, 2014
Short Course materials due from Instructors -
September 1, 2014
Housing Deadline -
September 15, 2014
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 22 - September 24, 2014
Marriott Wardman Park, Washington, DC